Title:

Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy

Authors:

Ana Teresa Paquete (U Lisboa)
Luis Silva Miguel (U Lisboa)
Ursula Becker (F Hoffman-La Roche Ltd, Basel)
Catarina Pereira (Roche Farmaceutica Quimica, Lda, Lisbon)
Carlos Gouveia Pinto (U Lisboa)

Journal:

Applied Health Economics and Health Policy

Year:

2017

Volume:

15

Number:

4

Pages:

501-512

JEL codes:

I11 - Analysis of Health Care Markets
D61 - Allocative Efficiency; Cost?Benefit Analysis

DOI:

10.1007/s40258-017-0321-2